Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Ecofriendly Versus Nylon Tooth Brushes on Cariogram Outcomes

NCT07467538 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-11-18
Last updated
2026-03-12

Condition(s) studied

Caries AssessmentCaries RiskOral Health

Investigational drug(s) / intervention(s)

Nylon based tooth brushEcofriendly toothbrush

Nylon based tooth brush: nylon based tooth brush will be used by children and adults age groups

Ecofriendly toothbrush: Children and adults group will use ecofriendly tooth brush

Study summary

The goal of this clinical trial is to evaluate the effectiveness of an eco-friendly toothbrush compared to a conventional nylon-based toothbrush on cariogram parameters in children and adults. It will also assess the impact of toothbrush type on caries risk factors. The main questions it aims to answer are:

Does the use of an eco-friendly toothbrush improve cariogram parameters compared to a nylon-based toothbrush? Does toothbrush type influence overall caries risk in children and adults?

Participants will:

1. Be randomly assigned to use either an eco-friendly toothbrush or a nylon-based toothbrush
2. Use the assigned toothbrush as part of their daily oral hygiene routine for the study period
3. Attend scheduled follow-up visits for clinical examination and cariogram assessment

Eligibility

Sex
ALL
Min age
8 Months
Max age
35 Months
Healthy volunteers
No
Inclusion Criteria: * Children's age group: Participants must be within the age range of 8 to 11 years. This age group is specifically chosen due to the prevalence of mixed dentition, which presents unique challenges and considerations for oral hygiene practices and assessment, and is considered as being a high caries risk profile according to the cariogram parameters. (Tavargeri \& Banerjee, 2021)(Lodha, Saraf, \& Jawdekar, 2023) Adults' age Group: Participants must be within the age range of 18 to 35 years consider as being a high caries risk profile according to the cariogram parameters. (AlDhawi et al., 2020; Fageeh et al., 2024) and (Fouad et al., 2022) Exclusion Criteria: * For the children's age group: * Lack of parental/guardian consent for participation. * Currently undergoing orthodontic treatment (fixed or removable appliances). * Children with special healthcare needs or those who are physically unwell at the time of the study. * Receipt of professional dental prophylaxis within the previous 3 months.(Tavargeri \& Banerjee, 2021) * Patient with a cariogenic diet.(Fouad et al., 2022) * For the adult group: * Currently undergoing orthodontic treatment (fixed or removable appliances). * Individuals with physical disabilities or any systemic health conditions (e.g., * diabetes) that could influence oral health or the ability to perform oral hygiene effectively. * Receipt of professional dental prophylaxis (e.g., scaling and polishing) within the previous 3 months.(Fageeh et al., 2024) * Patients with a cariogenic diet. (Fouad et al., 2022)

Primary outcome measure(s)

  • Caries risk profile determined by cariogram — 6 months follow up
    it determines if the patient is high, moderate and low caries risk after the study

Trial sites (1)

FacilityCityRegionStatus
Faculty of Dentistry, Suez university Suez Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07467538 on ClinicalTrials.gov ↗ ← All trials in Egypt